Actinium Pharmaceuticals, INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
AMEX
Actinium Pharmaceuticals' 2024 annual report details the company's financial results, pipeline advancements, and strategic focus on targeted radiotherapies for advanced cancers.
AMEX
10-K: Actinium Pharmaceuticals Reports on 2023 Progress, Highlights Iomab-B and Actimab-A Advancements
Actinium Pharmaceuticals' 2023 annual report details progress in clinical trials for Iomab-B and Actimab-A, along with financial updates and strategic priorities.